{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:00:57Z","timestamp":1777982457523,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Natural Science Foundation of Anhui Province","award":["2108085MH257"],"award-info":[{"award-number":["2108085MH257"]}]},{"name":"Anhui Medical University (Scientific Research Platform Improvement Project of Anhui Medical University","award":["2023xkjT061"],"award-info":[{"award-number":["2023xkjT061"]}]},{"DOI":"10.13039\/501100015936","name":"Guangdong Provincial Key Laboratory for Translational Cancer Research of Chinese Medicine, Guangzhou University of Chinese Medicine","doi-asserted-by":"publisher","award":["2023zhyx-B11"],"award-info":[{"award-number":["2023zhyx-B11"]}],"id":[{"id":"10.13039\/501100015936","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82570695"],"award-info":[{"award-number":["82570695"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00109-026-02666-w","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T11:14:10Z","timestamp":1775906050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Kv1.3 regulates macrophage immune function through PI3K\/AKT signaling pathway to alleviate metabolic dysfunction-associated steatohepatitis"],"prefix":"10.1007","volume":"104","author":[{"given":"Ting","family":"Ke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Jun","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-yuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye-tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6663-7257","authenticated-orcid":false,"given":"Bao-ming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"issue":"6","key":"2666_CR1","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP et al (2023) NAFLD Nomenclature consensus group. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol 79(6):1542\u20131556","journal-title":"J Hepatol"},{"issue":"4","key":"2666_CR2","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.jhep.2023.05.034","volume":"79","author":"WH Lim","year":"2023","unstructured":"Lim WH, Ng CH, Tan D, Tseng M, Xiao J, Yong JN, Zeng RW, Cho E, Tay P, Ang CZ et al (2023) Natural history of NASH cirrhosis in liver transplant waitlist registrants. J Hepatol 79(4):1015\u20131024","journal-title":"J Hepatol"},{"issue":"6","key":"2666_CR3","doi-asserted-by":"publisher","first-page":"e246","DOI":"10.1016\/j.jhep.2024.02.001","volume":"80","author":"X Fan","year":"2024","unstructured":"Fan X, Zhang B, Shi Y, Liu L, Zhao J (2024) Systemic metabolic abnormalities: key drivers of complications and mortality in MASLD. J Hepatol 80(6):e246\u2013e248","journal-title":"J Hepatol"},{"issue":"2","key":"2666_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, Mills PR, Keach JC, Lafferty HD, Stahler A et al (2015) Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 149(2):389\u201397.e10","journal-title":"Gastroenterology"},{"issue":"6","key":"2666_CR5","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","volume":"10","author":"QM Anstee","year":"2013","unstructured":"Anstee QM, Targher G, Day CP (2013) Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 10(6):330\u2013344","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"2666_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-022-00980-1","volume":"22","author":"S Pouwels","year":"2022","unstructured":"Pouwels S, Sakran N, Graham Y, Leal A, Pintar T, Yang W, Kassir R, Singhal R, Mahawar K, Ramnarain D (2022) Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disord 22(1):63","journal-title":"BMC Endocr Disord"},{"key":"2666_CR7","doi-asserted-by":"publisher","unstructured":"Qi X, Li J, Caussy C, Teng GJ, Loomba R (2024) Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease. Hepatology. https:\/\/doi.org\/10.1097\/HEP.0000000000000913","DOI":"10.1097\/HEP.0000000000000913"},{"issue":"2","key":"2666_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/ueg2.12491","volume":"12","author":"J Li","year":"2024","unstructured":"Li J, Delamarre A, Wong VW, de L\u00e9dinghen V (2024) Diagnosis and assessment of disease severity in patients with nonalcoholic fatty liver disease. United Eur Gastroenterol J 12(2):219\u2013225","journal-title":"United Eur Gastroenterol J"},{"issue":"5","key":"2666_CR9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","volume":"4","author":"J Li","year":"2019","unstructured":"Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, Fujii H, Wu Y, Kam LY, Ji F et al (2019) Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 4(5):389\u2013398","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"2666_CR10","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L (2023) The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 77(4):1335\u20131347","journal-title":"Hepatology"},{"issue":"12","key":"2666_CR11","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jama.2020.2298","volume":"323","author":"AC Sheka","year":"2020","unstructured":"Sheka AC, Adeyi O, Thompson J, Hameed B, Crawford PA, Ikramuddin S (2020) Nonalcoholic steatohepatitis: a review. JAMA 323(12):1175\u20131183 (Erratum in: JAMA. 2020 Apr 28;323(16):1619. 10.1001\/jama.2020.5249)","journal-title":"JAMA"},{"issue":"6","key":"2666_CR12","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","volume":"155","author":"F Kanwal","year":"2018","unstructured":"Kanwal F, Kramer JR, Mapakshi S, Natarajan Y, Chayanupatkul M, Richardson PA, Li L, Desiderio R, Thrift AP, Asch SM et al (2018) Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease. Gastroenterology 155(6):1828-1837.e2","journal-title":"Gastroenterology"},{"issue":"3","key":"2666_CR13","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3350\/cmh.2023.0384","volume":"30","author":"J Hwang","year":"2024","unstructured":"Hwang J, Hwang H, Shin H, Kim BH, Kang SH, Yoo JJ, Choi MY, Lee DE, Jun DW, Cho Y (2024) Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: a systematic review and meta-analysis. Clin Mol Hepatol 30(3):561\u2013576","journal-title":"Clin Mol Hepatol"},{"issue":"7","key":"2666_CR14","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ (2018) Mechanisms of NAFLD development and therapeutic strategies. Nat Med 24(7):908\u2013922","journal-title":"Nat Med"},{"issue":"5","key":"2666_CR15","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"Tilg H, Moschen AR (2010) Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52(5):1836\u20131846","journal-title":"Hepatology"},{"issue":"2","key":"2666_CR16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.tem.2015.11.008","volume":"27","author":"GN Ioannou","year":"2016","unstructured":"Ioannou GN (2016) The role of cholesterol in the pathogenesis of NASH. Trends Endocrinol Metab 27(2):84\u201395","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"2666_CR17","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s10620-016-4049-x","volume":"61","author":"M Arrese","year":"2016","unstructured":"Arrese M, Cabrera D, Kalergis AM, Feldstein AE (2016) Innate immunity and inflammation in NAFLD\/NASH. Dig Dis Sci 61(5):1294\u20131303","journal-title":"Dig Dis Sci"},{"issue":"1","key":"2666_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/JCI88881","volume":"127","author":"Y Koyama","year":"2017","unstructured":"Koyama Y, Brenner DA (2017) Liver inflammation and fibrosis. J Clin Invest 127(1):55\u201364","journal-title":"J Clin Invest"},{"issue":"2","key":"2666_CR19","first-page":"201","volume":"12","author":"B Fan","year":"2024","unstructured":"Fan B, Xie H, Tan Q, Li Q, Gong T, He B, Li Y, Chen L (2024) Role of exosomal modulation of macrophages in liver fibrosis. J Clin Transl Hepatol 12(2):201\u2013209","journal-title":"J Clin Transl Hepatol"},{"issue":"5","key":"2666_CR20","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","volume":"66","author":"AR Mridha","year":"2017","unstructured":"Mridha AR, Wree A, Robertson AAB, Yeh MM, Johnson CD, Van Rooyen DM, Haczeyni F, Teoh NC, Savard C, Ioannou GN et al (2017) NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. J Hepatol 66(5):1037\u20131046","journal-title":"J Hepatol"},{"issue":"3","key":"2666_CR21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","volume":"16","author":"K Kazankov","year":"2019","unstructured":"Kazankov K, J\u00f8rgensen SMD, Thomsen KL, M\u00f8ller HJ, Vilstrup H, George J, Schuppan D, Gr\u00f8nb\u00e6k H (2019) The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat Rev Gastroenterol Hepatol 16(3):145\u2013159","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"2666_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1600-065X.2009.00816.x","volume":"231","author":"MD Cahalan","year":"2009","unstructured":"Cahalan MD, Chandy KG (2009) The functional network of ion channels in T lymphocytes. Immunol Rev 231(1):59\u201387","journal-title":"Immunol Rev"},{"issue":"46","key":"2666_CR23","doi-asserted-by":"publisher","first-page":"17414","DOI":"10.1073\/pnas.0605136103","volume":"103","author":"C Beeton","year":"2006","unstructured":"Beeton C, Wulff H, Standifer NE, Azam P, Mullen KM, Pennington MW, Kolski-Andreaco A, Wei E, Grino A, Counts DR et al (2006) Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc Natl Acad Sci U S A 103(46):17414\u201317419","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2666_CR24","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1517\/14728220903018957","volume":"13","author":"S Rangaraju","year":"2009","unstructured":"Rangaraju S, Chi V, Pennington MW, Chandy KG (2009) Kv1.3 potassium channels as a therapeutic target in multiple sclerosis. Expert Opin Ther Targets 13(8):909\u2013924","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"2666_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-immunol-032414-112212","volume":"33","author":"S Feske","year":"2015","unstructured":"Feske S, Wulff H, Skolnik EY (2015) Ion channels in innate and adaptive immunity. Annu Rev Immunol 33(1):291\u2013353","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"2666_CR26","first-page":"4195","volume":"130","author":"S Sarkar","year":"2020","unstructured":"Sarkar S, Nguyen HM, Malovic E, Luo J, Langley M, Palanisamy BN, Singh N, Manne S, Neal M, Gabrielle M et al (2020) Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson\u2019s disease. J Clin Invest 130(8):4195\u20134212","journal-title":"J Clin Invest"},{"key":"2666_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2022.109394","volume":"730","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Liu L, Hu Y, Shen L, Li L, Wang Y (2022) Kv1.3 channel is involved in Ox-LDL-induced macrophage inflammation via ERK\/NF-\u03baB signaling pathway. Arch Biochem Biophys 730:109394","journal-title":"Arch Biochem Biophys"},{"key":"2666_CR28","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.abb.2015.12.013","volume":"591","author":"XH Kan","year":"2016","unstructured":"Kan XH, Gao HQ, Ma ZY, Liu L, Ling MY, Wang YY (2016) Kv1.3 potassium channel mediates macrophage migration in atherosclerosis by regulating ERK activity. Arch Biochem Biophys 591:150\u2013156","journal-title":"Arch Biochem Biophys"},{"issue":"4","key":"2666_CR29","doi-asserted-by":"publisher","first-page":"671","DOI":"10.7150\/ijbs.38950","volume":"16","author":"BM Wu","year":"2020","unstructured":"Wu BM, Liu JD, Bian E, Hu W, Huang C, Meng X, Zhang L, Lv X, Li J (2020) Blockage of Kv1.3 regulates macrophage migration in acute liver injury by targeting \u03b4-catenin through RhoA signaling. Int J Biol Sci 16(4):671\u2013681","journal-title":"Int J Biol Sci"},{"issue":"1","key":"2666_CR30","first-page":"103","volume":"45","author":"BM Wu","year":"2020","unstructured":"Wu BM, Liu JD, Li YH, Li J (2020) Margatoxin mitigates CCl4\u2011induced hepatic fibrosis in mice via macrophage polarization, cytokine secretion and STAT signaling. Int J Mol Med 45(1):103\u2013114","journal-title":"Int J Mol Med"},{"issue":"1","key":"2666_CR31","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ (2018) The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67(1):328\u2013357","journal-title":"Hepatology"},{"issue":"8","key":"2666_CR32","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti E, Pinzani M, Tsochatzis EA (2016) The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 65(8):1038\u20131048","journal-title":"Metabolism"},{"issue":"15","key":"2666_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155214","volume":"21","author":"J Chen","year":"2020","unstructured":"Chen J, Vitetta L (2020) Gut microbiota metabolites in NAFLD pathogenesis and therapeutic implications. Int J Mol Sci 21(15):5214","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2666_CR34","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/lt.25657","volume":"26","author":"TG Cotter","year":"2020","unstructured":"Cotter TG, Charlton M (2020) Nonalcoholic steatohepatitis after liver transplantation. Liver Transpl 26(1):141\u2013159","journal-title":"Liver Transpl"},{"issue":"22","key":"2666_CR35","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1001\/jama.2015.5370","volume":"313","author":"ME Rinella","year":"2015","unstructured":"Rinella ME (2015) Nonalcoholic fatty liver disease: a systematic review. JAMA 313(22):2263\u20132273 (Erratum in: JAMA. 2015 Oct 13;314(14):1521)","journal-title":"JAMA"},{"issue":"2","key":"2666_CR36","doi-asserted-by":"publisher","first-page":"108626","DOI":"10.1016\/j.celrep.2020.108626","volume":"34","author":"S Daemen","year":"2021","unstructured":"Daemen S, Gainullina A, Kalugotla G, He L, Chan MM, Beals JW, Liss KH, Klein S, Feldstein AE, Finck BN et al (2021) Dynamic shifts in the composition of resident and recruited macrophages influence tissue remodeling in NASH. Cell Rep 34(2):108626 (Erratum in: Cell Rep. 2022 Nov 15;41(7):111660. 10.1016\/j.celrep.2022.111660)","journal-title":"Cell Rep"},{"key":"2666_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101634","volume":"36","author":"F Xu","year":"2020","unstructured":"Xu F, Guo M, Huang W, Feng L, Zhu J, Luo K, Gao J, Zheng B, Kong LD, Pang T et al (2020) Annexin A5 regulates hepatic macrophage polarization via directly targeting PKM2 and ameliorates NASH. Redox Biol 36:101634","journal-title":"Redox Biol"},{"issue":"1\u20132","key":"2666_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/14728222.2024.2315021","volume":"28","author":"M Navarro-P\u00e9rez","year":"2024","unstructured":"Navarro-P\u00e9rez M, Capera J, Benavente-Garcia A, Cassinelli S, Colomer-Molera M, Felipe A (2024) Kv1.3 in the spotlight for treating immune diseases. Expert Opin Ther Targets 28(1\u20132):67\u201382","journal-title":"Expert Opin Ther Targets"},{"key":"2666_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116651","volume":"175","author":"S Cheng","year":"2024","unstructured":"Cheng S, Jiang D, Lan X, Liu K, Fan C (2024) Voltage-gated potassium channel 1.3: a promising molecular target in multiple disease therapy. Biomed Pharmacother 175:116651","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"2666_CR40","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/cvr\/cvab133","volume":"118","author":"R Immler","year":"2022","unstructured":"Immler R, Nadolni W, Bertsch A, Morikis V, Rohwedder I, Masgrau-Alsina S, Schroll T, Yevtushenko A, Soehnlein O, Moser M et al (2022) The voltage-gated potassium channel KV1.3 regulates neutrophil recruitment during inflammation. Cardiovasc Res 118(5):1289\u20131302","journal-title":"Cardiovasc Res"},{"key":"2666_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14644","volume":"8","author":"EY Chiang","year":"2017","unstructured":"Chiang EY, Li T, Jeet S, Peng I, Zhang J, Lee WP, DeVoss J, Caplazi P, Chen J, Warming S et al (2017) Potassium channels Kv1.3 and KCa3.1 cooperatively and compensatorily regulate antigen-specific memory T cell functions. Nat Commun 8:14644","journal-title":"Nat Commun"},{"issue":"15","key":"2666_CR42","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/j.bpj.2023.08.011","volume":"123","author":"J Capera","year":"2024","unstructured":"Capera J, Jainarayanan A, Navarro-P\u00e9rez M, Valvo S, Demetriou P, Depoil D et al (2024) Dynamics and spatial organization of Kv1.3 at the immunological synapse of human CD4+ T cells. Biophys J 123(15):2271\u20132281","journal-title":"Biophys J"},{"issue":"12","key":"2666_CR43","first-page":"714841","volume":"23","author":"J Capera","year":"2021","unstructured":"Capera J, Jainarayanan A, Navarro-P\u00e9rez M, Valvo S, Demetriou P, Depoil D, Estadella I, Kvalvaag A, Felce JH, Felipe A et al (2021) Kv1.3 Channel Up-Regulation in Peripheral Blood T Lymphocytes of Patients With Multiple Sclerosis. Front Pharmacol 23(12):714841","journal-title":"Front Pharmacol"},{"issue":"5","key":"2666_CR44","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.3390\/cancers14051217","volume":"14","author":"JL Goggi","year":"2022","unstructured":"Goggi JL, Khanapur S, Ramasamy B, Hartimath SV, Rong TJ, Cheng P, Tan YX, Yeo XY, Jung S, Goay SSM et al (2022) Imaging Kv1.3 expressing memory T Cells as a marker of immunotherapy response. Cancers (Basel) 14(5):1217","journal-title":"Cancers (Basel)"},{"issue":"24","key":"2666_CR45","doi-asserted-by":"publisher","first-page":"E2239","DOI":"10.1073\/pnas.1221206110","volume":"110","author":"SK Upadhyay","year":"2013","unstructured":"Upadhyay SK, Eckel-Mahan KL, Mirbolooki MR, Tjong I, Griffey SM, Schmunk G, Koehne A, Halbout B, Iadonato S, Pedersen B et al (2013) Selective Kv1.3 channel blocker as therapeutic for obesity and insulin resistance. Proc Natl Acad Sci U S A 110(24):E2239-48","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-026-02666-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-026-02666-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-026-02666-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T12:02:21Z","timestamp":1775908941000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-026-02666-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2666"],"URL":"https:\/\/doi.org\/10.1007\/s00109-026-02666-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7259682\/v1","asserted-by":"object"}]},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by the Institutional Animal Care and Use Committee of Anhui Medical University (Approval No. LLSC20241623). Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors have no conflict of interests related to this publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"63"}}